CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 82 enrolled
Drug / intervention
Naltrexone +1 moredrug
Likely dose
Not stated in record
Key inclusion· 4
  • ✓Age 18–35 years old
  • ✓Good overall health
  • ✓Fluent in English
  • ✓Right-handed (required for fMRI scanning)
Key exclusion· 11
  • ✕Current or past self-reported diagnoses of physical or mental illness
  • ✕Depressive symptoms (PHQ-9 score) >13
  • ✕Positive urine drug screen (THC, opiates, cocaine, amphetamine, methamphetamine)
  • ✕Positive urine pregnancy test

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02818036
NCT02818036N/ACompleted
CompareCT.gov

An fMRI Study of Opioid-related Changes in Neural Activity

Tristen Inagaki·interventional·Posted Jun 29, 2016·Updated Jul 23, 2019

In Brief

A clinical study evaluating Naltrexone and Placebo for Social Acceptance. Completed, enrolled 82 participants across 1 site.

Detailed Summary

The purpose of the study is to explore the effect of blocking opioids on affiliation-related neural activity.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSocial Acceptance
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJun 29, 2016
Enrollment StartAug 1, 2016
Primary CompletionJun 21, 2018
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 10.0 years ago

Interventions

Naltrexonedrug

Placebodrug